Cancer Research Meeting Calendar  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3107-3110, June 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishida, N.
Right arrow Articles by Ishizaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishida, N.
Right arrow Articles by Ishizaki, K.

Amplification and Overexpression of the Cyclin D1 Gene in Aggressive Human Hepatocellular Carcinoma1

Naoshi Nishida, Yoshihiro Fukuda, Toshiki Komeda, Ryuichi Kita, Takehiro Sando, Motonobu Furukawa, Masahiro Amenomori, Icho Shibagaki, Kazuwa Nakao, Mituo Ikenaga and Kanji Ishizaki2

Radiation Biology Center, Kyoto University, Yoshida-Konoecho, Sakyo-ku, Kyoto 606 [N. N., I. S., M. I., K. I.]; and Second Department of Internal Medicine [N. N., Y. F., T. K., R. K., T. S., M. F., M. A., K. N.] and First Department of Surgery [I. S.], Kyoto University Faculty of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606, Japan

We analyzed the genetic alterations of the cyclin D1 and INT-2 genes in hepatocellular carcinomas (HCCs) from 45 patients. Among these, expression of the cyclin D1 mRNA was also analyzed in 18 of them by Northern blotting. The cyclin D1 gene was amplified 3–16 fold in five HCCs (11%); among these, the INT-2 gene was also amplified 2–10 fold in four HCCs. We analyzed the mRNA of cyclin D1 in four HCCs with gene amplifications, and 6–10 fold overexpressions were detected in all of them. Because the cyclin D1 gene was amplified in patients at an advanced stage of HCC with rapid tumor growth, it appeared to be associated with the aggressive behavior of tumors. Studies on loss of heterozygosity on chromosome 13q, where the retinoblastoma (RB) gene is located, indicated that all HCCs with an amplified cyclin D1 gene retained heterozygosity on chromosome 13q. These results suggest that amplification and overexpression of the cyclin D1 gene result in the rapid growth of a subset of HCC, even though the function of the RB gene is retained.

1 This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture, Japan.

2 To whom requests for reprints should be addressed.

Received 3/ 7/94. Accepted 5/ 4/94.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
N.-S. Oh, J.-S. Park, Y.-J. Jeon, J.-H. Oh, S.-Y. Jeong, J.-O. Yang, Y.-W. Park, H.-S. Yoo, and N.-S. Kim
Generation of Expression Clone Set for Functional Proteomics of Human Gastric and Liver Cancers
Experimental Biology and Medicine, October 1, 2009; 234(10): 1220 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Song, K. Krishnan, K. Liu, and R. S. Bresalier
Polyphenon E Inhibits the Growth of Human Barrett's and Aerodigestive Adenocarcinoma Cells by Suppressing Cyclin D1 Expression
Clin. Cancer Res., January 15, 2009; 15(2): 622 - 631.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Y. Chiang, A. Villanueva, Y. Hoshida, J. Peix, P. Newell, B. Minguez, A. C. LeBlanc, D. J. Donovan, S. N. Thung, M. Sole, et al.
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Cancer Res., August 15, 2008; 68(16): 6779 - 6788.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, E. Domany, E. Galun, et al.
Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice
Mol. Cancer Res., November 1, 2007; 5(11): 1159 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Yasui, H. Yamamoto, C. Y. Ngan, B. Damdinsuren, Y. Sugita, H. Fukunaga, J. Gu, M. Maeda, I. Takemasa, M. Ikeda, et al.
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
Clin. Cancer Res., August 1, 2006; 12(15): 4720 - 4729.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Huynh, K. C. Soo, P. K.H. Chow, L. Panasci, and E. Tran
Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs.
Clin. Cancer Res., July 15, 2006; 12(14): 4306 - 4314.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Katzenellenbogen, O. Pappo, H. Barash, N. Klopstock, L. Mizrahi, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, L. A. Mitchell, et al.
Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the mdr2-knockout mice.
Cancer Res., April 15, 2006; 66(8): 4001 - 4010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Sterpetti, L. Marucci, C. Candelaresi, D. Toksoz, G. Alpini, L. Ugili, G. S. Baroni, G. Macarri, and A. Benedetti
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G624 - G632.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Patil, I. Gutgemann, J. Zhang, C. Ho, S.-T. Cheung, D. Ginzinger, R. Li, K. J. Dykema, S. So, S.-T. Fan, et al.
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma
Carcinogenesis, December 1, 2005; 26(12): 2050 - 2057.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. C. Lewis, D. S. Klimstra, N. D. Socci, S. Xu, J. A. Koutcher, and H. E. Varmus
The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular Carcinoma
Mol. Cell. Biol., February 15, 2005; 25(4): 1228 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
L. ZENDER, W. XUE, C. CORDON-CARDO, G.J. HANNON, R. LUCITO, S. POWERS, P. FLEMMING, M.S. SPECTOR, and S.W. LOWE
Generation and Analysis of Genetically Defined Liver Carcinomas Derived from Bipotential Liver Progenitors
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 251 - 261.
[Abstract] [PDF]


Home page
J. Clin. Pathol.Home page
A Ramburan, F Oladiran, C Smith, G P Hadley, and D Govender
Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of {beta} catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy
J. Clin. Pathol., January 1, 2005; 58(1): 44 - 50.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
O. Okochi, K. Hibi, M. Sakai, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao
Methylation-Mediated Silencing of SOCS-1 Gene in Hepatocellular Carcinoma Derived from Cirrhosis
Clin. Cancer Res., November 1, 2003; 9(14): 5295 - 5298.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al.
Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643
Carcinogenesis, April 1, 2003; 24(4): 757 - 770.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. W. Kim and X. W. Wang
Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?
Carcinogenesis, March 1, 2003; 24(3): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
B.-Z. Yuan, X. Zhou, D. B. Zimonjic, M. E. Durkin, and N. C. Popescu
Amplification and Overexpression of the EMS 1 Oncogene, a Possible Prognostic Marker, in Human Hepatocellular Carcinoma
J. Mol. Diagn., February 1, 2003; 5(1): 48 - 53.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
R. B. Birrer, D. Birrer, and J. V. Klavins
Hepatocellular Carcinoma and Hepatitis Virus
Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 39 - 54.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Fukuda, M. Ebara, M. Okuyama, N. Sugiura, M. Yoshikawa, H. Saisho, R. Shimizu, N. Motoji, A. Shigematsu, and T. Watayo
Increased metabolizing activities of the tricarboxylic acid cycle and decreased drug metabolism in hepatocellular carcinoma
Carcinogenesis, December 1, 2002; 23(12): 2019 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
O. Okochi, K. Hibi, T. Uemura, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao
Detection of Mitochondrial DNA Alterations in the Serum of Hepatocellular Carcinoma Patients
Clin. Cancer Res., September 1, 2002; 8(9): 2875 - 2878.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Suzui, M. Masuda, J. T. E. Lim, C. Albanese, R. G. Pestell, and I. B. Weinstein
Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p21CIP1 and Inhibition of Expression of Cyclin D1
Cancer Res., July 15, 2002; 62(14): 3997 - 4006.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Harada, H. Miyoshi, N. Murai, H. Oshima, Y. Tamai, M. Oshima, and M. M. Taketo
Lack of Tumorigenesis in the Mouse Liver after Adenovirus-mediated Expression of a Dominant Stable Mutant of {beta}-Catenin
Cancer Res., April 1, 2002; 62(7): 1971 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Inagawa, M. Itabashi, S. Adachi, T. Kawamoto, M. Hori, J. Shimazaki, F. Yoshimi, and K. Fukao
Expression and Prognostic Roles of {beta}-Catenin in Hepatocellular Carcinoma: Correlation with Tumor Progression and Postoperative Survival
Clin. Cancer Res., February 1, 2002; 8(2): 450 - 456.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Li, M. Tondravi, J. Liu, E. Smith, C. C. Haudenschild, M. Kaczmarek, and X. Zhan
Cortactin Potentiates Bone Metastasis of Breast Cancer Cells
Cancer Res., September 1, 2001; 61(18): 6906 - 6911.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. G. Deane, M. A. Parker, R. Aramandla, L. Diehl, W.-J. Lee, M. K. Washington, L. B. Nanney, Y. Shyr, and R. D. Beauchamp
Hepatocellular Carcinoma Results from Chronic Cyclin D1 Overexpression in Transgenic Mice
Cancer Res., July 1, 2001; 61(14): 5389 - 5395.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Uto, A. Ido, A. Moriuchi, Y. Onaga, K. Nagata, M. Onaga, Y. Tahara, T. Hori, S. Hirono, K. Hayashi, et al.
Transduction of Antisense Cyclin D1 Using Two-step Gene Transfer Inhibits the Growth of Rat Hepatoma Cells
Cancer Res., June 1, 2001; 61(12): 4779 - 4783.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Cadoret, C. Ovejero, S. Saadi-Kheddouci, E. Souil, M. Fabre, B. Romagnolo, A. Kahn, and C. Perret
Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of {beta}-Catenin
Cancer Res., April 1, 2001; 61(8): 3245 - 3249.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
H. Takayasu, H. Horie, E. Hiyama, T. Matsunaga, Y. Hayashi, Y. Watanabe, S. Suita, M. Kaneko, F. Sasaki, K. Hashizume, et al.
Frequent Deletions and Mutations of the {beta}-Catenin Gene Are Associated with Overexpression of Cyclin D1 and Fibronectin and Poorly Differentiated Histology in Childhood Hepatoblastoma
Clin. Cancer Res., April 1, 2001; 7(4): 901 - 908.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
L. C. Pulling, D. M. Klinge, and S. A. Belinsky
p16INK4a and {beta}-catenin alterations in rat liver tumors induced by NNK
Carcinogenesis, March 1, 2001; 22(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. F. Calvisi, V. M. Factor, R. Loi, and S. S. Thorgeirsson
Activation of {beta}-Catenin during Hepatocarcinogenesis in Transgenic Mouse Models: Relationship to Phenotype and Tumor Grade
Cancer Res., March 1, 2001; 61(5): 2085 - 2091.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Dosaka-Akita, F. Hommura, T. Mishina, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami
A Risk-Stratification Model of Non-Small Cell Lung Cancers Using Cyclin E, Ki-67, and ras p21: Different Roles of G1 Cyclins in Cell Proliferation and Prognosis
Cancer Res., March 1, 2001; 61(6): 2500 - 2504.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
A.-M. Hui, X. Li, Y.-Z. Shi, T. Takayama, G. Torzilli, and M. Makuuchi
Cyclin D1 Overexpression Is a Critical Event in Gallbladder Carcinogenesis and Independently Predicts Decreased Survival for Patients with Gallbladder Carcinoma
Clin. Cancer Res., November 1, 2000; 6(11): 4272 - 4277.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-C. Soria, S. J. Jang, F. R. Khuri, K. Hassan, D. Liu, W. K. Hong, and L. Mao
Overexpression of Cyclin B1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication
Cancer Res., August 1, 2000; 60(15): 4000 - 4004.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
P. Polakis
Wnt signaling and cancer
Genes & Dev., August 1, 2000; 14(15): 1837 - 1851.
[Full Text]


Home page
CarcinogenesisHome page
K. Takaba, K. Saeki, K. Suzuki, H. Wanibuchi, and S. Fukushima
Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate
Carcinogenesis, April 1, 2000; 21(4): 691 - 700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S.-L. Y. Feng, Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles
The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas
Am. J. Pathol., April 1, 2000; 156(4): 1253 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Huang, H. Fujii, A. Sankila, B. M. Mahler-Araujo, M. Matsuda, G. Cathomas, and H. Ohgaki
{beta}-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection
Am. J. Pathol., December 1, 1999; 155(6): 1795 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Carlson, T. Lahusen, S. Singh, A. Loaiza-Perez, P. J. Worland, R. Pestell, C. Albanese, E. A. Sausville, and A. M. Senderowicz
Down-Regulation of Cyclin D1 by Transcriptional Repression in MCF-7 Human Breast Carcinoma Cells Induced by Flavopiridol
Cancer Res., September 1, 1999; 59(18): 4634 - 4641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. T. V. Nhieu, C. A. Renard, Y. Wei, D. Cherqui, E. S. Zafrani, and M. A. Buendia
Nuclear Accumulation of Mutated {beta}-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell Proliferation
Am. J. Pathol., September 1, 1999; 155(3): 703 - 710.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Q. Yang, H. Z. Lin, M. Yin, J. H. Albrecht, and A. M. Diehl
Effects of chronic ethanol consumption on cytokine regulation of liver regeneration
Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G696 - G704.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
R. J. A. M. Michalides, N. M. J. van Veelen, P. M. P. Kristel, A. A. M. Hart, B. M. Loftus, F. J. M. Hilgers, and A. J. M. Balm
Overexpression of Cyclin D1 Indicates a Poor Prognosis in Squamous Cell Carcinoma of the Head and Neck
Arch Otolaryngol Head Neck Surg, May 1, 1997; 123(5): 497 - 502.
[Abstract] [PDF]


Home page
Genes Dev.Home page
H Wu, M Wade, L Krall, J Grisham, Y Xiong, and T Van Dyke
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Genes & Dev., February 1, 1996; 10(3): 245 - 260.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.